Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pinedo

Showing results (311-320 of 569) with videos related to

Pageof 57
Sort By:
European Journal of Cancer & Clinical Oncology|February 1, 1988
Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG)M van Glabbeke, J Renard, H M Pinedo, et al.
Cancer Gene Therapy|July 6, 2000
Targeting of adenoviral vectors through a bispecific single-chain antibodyH J Haisma, J Grill, D T Curiel, et al.
Oncology Research|June 22, 2001
Differences in the induction of DNA damage, cell cycle arrest, and cell death by 5-fluorouracil and antifolatesH H Backus, H M Pinedo, D Wouters, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
In vitro sequence-dependent synergistic effect of suramin and camptothecinR Lopez, G J Peters, E Smitskamp-Wilms, et al.
International Journal of Cancer|June 9, 1995
Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenograftsH J Broxterman, N Feller, C M Kuiper, et al.
British Journal of Cancer|November 1, 1993
Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cellsC H Versantvoort, G J Schuurhuis, H M Pinedo, et al.
British Journal of Cancer|March 1, 1994
A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2A C Ogilvie, J W Baars, A J Eerenberg, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomasR Abele, M Clavel, P Dodion, et al.
Leukemia|July 1, 1997
Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemiaH J Broxterman, J Lankelma, H M Pinedo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomasH M Verheul, K Hoekman, F Lupu, et al.
Pageof 57

Showing results (311-320 of 569) with videos related to

Sort By:
Pageof 57
European Journal of Cancer & Clinical Oncology|February 1, 1988
Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG)M van Glabbeke, J Renard, H M Pinedo, et al.
Cancer Gene Therapy|July 6, 2000
Targeting of adenoviral vectors through a bispecific single-chain antibodyH J Haisma, J Grill, D T Curiel, et al.
Oncology Research|June 22, 2001
Differences in the induction of DNA damage, cell cycle arrest, and cell death by 5-fluorouracil and antifolatesH H Backus, H M Pinedo, D Wouters, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
In vitro sequence-dependent synergistic effect of suramin and camptothecinR Lopez, G J Peters, E Smitskamp-Wilms, et al.
International Journal of Cancer|June 9, 1995
Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenograftsH J Broxterman, N Feller, C M Kuiper, et al.
British Journal of Cancer|November 1, 1993
Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cellsC H Versantvoort, G J Schuurhuis, H M Pinedo, et al.
British Journal of Cancer|March 1, 1994
A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2A C Ogilvie, J W Baars, A J Eerenberg, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomasR Abele, M Clavel, P Dodion, et al.
Leukemia|July 1, 1997
Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemiaH J Broxterman, J Lankelma, H M Pinedo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomasH M Verheul, K Hoekman, F Lupu, et al.
Pageof 57